| Dr Mickey M Tseng, MD | |
|
2228 Liliha St, Suite #101, Honolulu, HI 96817-1650 | |
| (808) 531-5070 | |
| (808) 531-5074 |
| Full Name | Dr Mickey M Tseng |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 32 Years |
| Location | 2228 Liliha St, Honolulu, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073624276 | NPI | - | NPPES |
| 08770201 | Medicaid | HI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD-10396 (Hawaii) | Primary |
| Entity Name | Mickey M.y. Tseng, M.d., M.p.h., Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770652687 PECOS PAC ID: 8224101399 Enrollment ID: O20080723000079 |
News Archive
The Dallas Morning News reports that rural health providers "are keeping a wary eye on proposed health care changes under debate in Congress. ... Democrats and Republicans from rural areas in the South and Midwest succeeded in getting some relief for the rural health care system written into the Senate and House bills under debate.
Age-related macular degeneration (AMD) and its associated vision loss may be connected to the quality of carbohydrates an individual consumes.
Glioblastoma is the most common ma-lignant primary brain tumor in adults. The aggressive growth manner, characterized by marked angiogenesis and extensive tumor cell invasion into normal brain parenchyma with frequent formation of tumor microsatellites at distal sites, makes eradication impossible even after extensive microsurgical resection combined with current standard chemoradiation and adjuvant temozolomide.
The U.S. Food and Drug Administration (FDA) today warned consumers to avoid using tubes of toothpaste labeled as made in China, and issued an import alert to prevent toothpaste containing the poisonous chemical diethylene glycol (DEG) from entering the United States.
Thermo Fisher Scientific, the world leader in serving science, today announced that it has completed its acquisition of Life Technologies Corporation (NASDAQ: LIFE) for $76.13 ($76.1311786) in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of $1.5 billion in net debt. The completion of the transaction follows the receipt of all required regulatory approvals.
› Verified 5 days ago
| Entity Name | Healthcare Partners, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144673252 PECOS PAC ID: 9638449515 Enrollment ID: O20170726000566 |
News Archive
The Dallas Morning News reports that rural health providers "are keeping a wary eye on proposed health care changes under debate in Congress. ... Democrats and Republicans from rural areas in the South and Midwest succeeded in getting some relief for the rural health care system written into the Senate and House bills under debate.
Age-related macular degeneration (AMD) and its associated vision loss may be connected to the quality of carbohydrates an individual consumes.
Glioblastoma is the most common ma-lignant primary brain tumor in adults. The aggressive growth manner, characterized by marked angiogenesis and extensive tumor cell invasion into normal brain parenchyma with frequent formation of tumor microsatellites at distal sites, makes eradication impossible even after extensive microsurgical resection combined with current standard chemoradiation and adjuvant temozolomide.
The U.S. Food and Drug Administration (FDA) today warned consumers to avoid using tubes of toothpaste labeled as made in China, and issued an import alert to prevent toothpaste containing the poisonous chemical diethylene glycol (DEG) from entering the United States.
Thermo Fisher Scientific, the world leader in serving science, today announced that it has completed its acquisition of Life Technologies Corporation (NASDAQ: LIFE) for $76.13 ($76.1311786) in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of $1.5 billion in net debt. The completion of the transaction follows the receipt of all required regulatory approvals.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mickey M Tseng, MD 2228 Liliha St, Ste 101, Honolulu, HI 96817-1651 Ph: (808) 484-1169 | Dr Mickey M Tseng, MD 2228 Liliha St, Suite #101, Honolulu, HI 96817-1650 Ph: (808) 531-5070 |
News Archive
The Dallas Morning News reports that rural health providers "are keeping a wary eye on proposed health care changes under debate in Congress. ... Democrats and Republicans from rural areas in the South and Midwest succeeded in getting some relief for the rural health care system written into the Senate and House bills under debate.
Age-related macular degeneration (AMD) and its associated vision loss may be connected to the quality of carbohydrates an individual consumes.
Glioblastoma is the most common ma-lignant primary brain tumor in adults. The aggressive growth manner, characterized by marked angiogenesis and extensive tumor cell invasion into normal brain parenchyma with frequent formation of tumor microsatellites at distal sites, makes eradication impossible even after extensive microsurgical resection combined with current standard chemoradiation and adjuvant temozolomide.
The U.S. Food and Drug Administration (FDA) today warned consumers to avoid using tubes of toothpaste labeled as made in China, and issued an import alert to prevent toothpaste containing the poisonous chemical diethylene glycol (DEG) from entering the United States.
Thermo Fisher Scientific, the world leader in serving science, today announced that it has completed its acquisition of Life Technologies Corporation (NASDAQ: LIFE) for $76.13 ($76.1311786) in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of $1.5 billion in net debt. The completion of the transaction follows the receipt of all required regulatory approvals.
› Verified 5 days ago
Dr. Wayne K Nadamoto, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1520 Liliha St Ste 303, Honolulu, HI 96817 Phone: 808-538-1457 Fax: 808-538-3161 | |
Peter V. Mathews, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1010 Pensacola St, Honolulu, HI 96814 Phone: 808-432-2000 | |
Lansing Leiohu Sugita, Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1301 Punchbowl St, Honolulu, HI 96813 Phone: 808-691-1000 | |
Dr. David A. Vasconcellos, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Anthony Michael Barcia, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1401 S Beretania St Ste 750, Honolulu, HI 96814 Phone: 808-686-4010 | |
Darryl M Kan, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1380 Lusitana St, Suite 608, Honolulu, HI 96813 Phone: 808-536-2261 Fax: 808-538-3957 | |
Dr. Brian J. Mannino, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 |